SCHEMBL1318607

SCHEMBL1318607

CC[C@@H]1CCCN1c1cc(-c2cc(F)c(C#N)c(OC)c2)nc(NC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.37
ADORA1 P30542 6/20 0.37
PIK3CD O00329 2/20 0.35
PIK3C2B O00750 2/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CG P48736 2/20 0.35
IMPDH2 P12268 3/20 0.34
LRRK2 Q5S007 2/20 0.33
MAPT P10636 2/20 0.33
PDPK1 O15530 1/20 0.32
AURKB Q96GD4 1/20 0.32
ADORA2B P29275 1/20 0.32
AR P10275 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1318108 0.92 ADORA2A (0.33) ADORA2AADORA1PIK3CDPIK3C2BPIK3CB
SCHEMBL1318731 0.92 AR (0.35) ADORA2AADORA1MAPTPDPK1AURKB
SCHEMBL1317696 0.88 ADORA1 (0.38) ADORA2AADORA1PIK3CDPIK3C2BPIK3CB
SCHEMBL1318612 0.88 PDPK1 (0.39) ADORA2AADORA1PIK3CDPIK3C2BPIK3CB
SCHEMBL1317860 0.87 ADORA1 (0.37) ADORA2AADORA1PIK3CDPIK3C2BPIK3CB
SCHEMBL1319227 0.86 MAP4K1 (0.33) ADORA2AADORA1PDPK1AURKBADORA2B
SCHEMBL1317511 0.82 EGLN2 (0.36) PIK3CGLRRK2PDPK1AURKB
SCHEMBL1318311 0.79 EGLN2 (0.40) ADORA2AADORA1PIK3CGLRRK2PDPK1
SCHEMBL1319290 0.79 PDPK1 (0.42) ADORA1PDPK1AURKBADORA2BMAP4K1
SCHEMBL1317566 0.78 AURKA (0.39) ADORA2AADORA1LRRK2PDPK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 EP disclosed
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 EP disclosed
US-8697685-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2014-04-15 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed
WO-2010059658-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275611-A1 CHEMICAL COMPOUNDS PDK1, PDK2, PDK3 ADORA2A 1537/4885ADORA1 1104/4885PIK3CD 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.